Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Open-Label Add-On for Partial Seizures
NCT00141336Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 1999
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, open-label, single-arm trial of pregabalin in focal seizures, sponsored by Pfizer. Primary endpoint: Safety and Tolerability. Started Nov 1999; status: completed.
02
Drugs
pregabalin
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00141336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141336.